Tuesday, February 16, 2021

Daily Trading Analysis 16.02.2021

Trading Analysis of AUD/USD
The authorities of the Australian state of Victoria announced the introduction of strict quarantine from February 13 to 18 due to an outbreak of coronavirus in the administrative center of the region - Melbourne. This was announced by the head of the state government Daniel Andrews on Friday.

Our Analysis:

Provided that the currency pair is traded above 0.7780, follow the recommendations below:
  • Time frame: 30 min
  • Recommendation: long position
  • Entry point: 0.7801
  • Take Profit 1: 0.7820
  • Take Profit 2: 0.7840

Alternative scenario:

In case of breakdown of the level 0.7780, follow the recommendations below:
  • Time frame: 30 min
  • Recommendation: short position
  • Entry point: 0.7780
  • Take Profit 1: 0.7765
  • Take Profit 2: 0.7750

Trading Analysis of Dow Jones 30 Index
The dollar dropped to a three-week low on Tuesday, sterling hit a near three-year high, and commodity currencies rose as progress on vaccinations and investors' hopes for a global economic recovery. The dollar index to a basket of major currencies was down 0.2% to 90.299. The euro rose 0.08% to $1.2137. Investors are weighing whether the U.S. will be the sole leader of the recovery, which will support the dollar, or whether it will be broader - and that will be negative for the dollar.

Our Analysis:

Provided that the index is traded above 31300.00, follow the recommendations below:
  • Time frame: H4
  • Recommendation: long position
  • Entry point: 31671.00
  • Take Profit 1: 32100.00
  • Take Profit 2: 32300.00

Alternative scenario:

In case of breakdown of the level 31300.00, follow the recommendations below:
  • Time frame: H4
  • Recommendation: short position
  • Entry point: 31300.00
  • Take Profit 1: 30700.00
  • Take Profit 2: 29960.00

Fundamental Trading
Analysis of Pfizer 
Pfizer has underperformed the S&P 500 in 2020. The same situation was one year before, as well as in 2017 and 2016. You may have noticed that we didn't mention 2018, which was the only year in the last five years when a major pharmaceutical company managed to outperform the broad market index. If looking at historical returns was the best way to foretell coming profits, Pfizer's prospects wouldn't be so good.


Our Analysis:

 While the price is above 34.10, follow the recommendations below:
  • Time frame: D1
  • Recommendation: long position
  • Entry point: 35.00
  • Take Profit 1: 39.30
  • Take Profit 2: 43.0

Alternative scenario:

If the level 34.10 is broken-down, follow the recommendations below.
  • Time frame: D1
  • Recommendation: short position
  • Entry point: 34.10
  • Take Profit 1: 32.60
  • Take Profit 2: 29.70

Risk Warning: Forex and CFD trading carry a high degree of risk. As such they may not be suitable for all investors. Investors should ensure they fully understand the risks associated with CFD trading before deciding to trade. Investors may choose to seek independent advice and should not risk more than they are prepared to lose.

No comments:

Post a Comment

FREE Access Link: Top 7 Stocks For 2025

Dear reader, Eric Fry's brand-new research report, Top 7 Stocks for 2025 , is ready for you. Click here to...